serine (or cysteine) peptidase inhibitor, clade E, member 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| blood coagulation | ||
| negative regulation of cell population proliferation | ||
| response to wounding | ||
| negative regulation of peptidase activity | ||
| negative regulation of platelet activation |
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytosol | ||
| cytosol | ||
| platelet alpha granule | ||
| neuromuscular junction | ||
| neuronal cell body |
| GO Term | Evidence Code | PMID |
|---|---|---|
| serine-type endopeptidase inhibitor activity | ||
| serine-type endopeptidase inhibitor activity | ||
| serine-type endopeptidase inhibitor activity | ||
| signaling receptor binding | ||
| signaling receptor binding |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026